Research & Discovery

Mubadala Investment Company (Mubadala) and Siemens Energy, one of the world’s leading energy technology companies, have signed a Memorandum of Understanding (MoU) with the intention of creating a strategic partnership to drive investment and development of advanced technology, manufacture of equipment, and green hydrogen and synthetic fuel production. The initial focus of activity will be in Abu Dhabi and it is intended this will be expanded to international markets over time.

Partnership supports the next phase of the Emirate's ambition to translate genomic insights into advanced therapies, clinical research and future manufacturing capabilities

In the programme’s initial phase, screening is being offered on a voluntary basis at Kanad Hospital and Danat Al Emarat Hospital, in partnership with M42

M42, a global health leader powered by technology, announced a strategic collaboration with AstraZeneca and SOPHiA GENETICS to bring cutting-edge liquid biopsy testing to the UAE, aimed at advancing cancer diagnosis, informing treatment decisions, and enabling faster, accurate biomarker testing across a broad range of cancers.